Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

507.00p
   
  • Change Today:
      17.00p
  • 52 Week High: 913.00
  • 52 Week Low: 424.00
  • Currency: UK Pounds
  • Shares Issued: 121.05m
  • Volume: 373,615
  • Market Cap: £613.72m
  • RiskGrade: 125
  • Beta: 0.03

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest ShareCast News

Director dealings: Oxford Biomedica chair ups stake

By Benjamin Chiou

Date: Thursday 24 Sep 2026

(Sharecast News) - The largest market purchase of shares in London on Thursday came from Oxford Biomedica's chair Roch Doliveux. who upped his stake in the cell and gene therapy company after a sharp drop in the stock over the year to date.

OXB Regulatory News

PDMR Dealing 25-Sep-2026 14:53 RNS
PDMR Dealing 24-Sep-2026 13:58 RNS
Holding(s) in Company 22-Sep-2026 07:00 RNS
Interim Results 22-Sep-2026 07:00 RNS
Holding(s) in Company 21-Sep-2026 10:43 RNS

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 507.00p
Change Today 17.00p
% Change 3.47 %
52 Week High 913.00
52 Week Low 424.00
Volume 373,615
Shares Issued 121.05m
Market Cap £613.72m
Beta 0.03
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 4
Sell 0
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 25-Sep-2026

Time Volume / Share Price
16:35 88,280 @ 507.00p
16:35 1 @ 507.00p
16:35 577 @ 507.00p
16:35 334 @ 507.00p
16:35 870 @ 507.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page